This week the Vanderbilt University Board of Trust took the first steps toward the expansion of Monroe Carell Jr. Children's Hospital at Vanderbilt, approving $5.4 million in planning fees for the proposed addition.

When biological molecules kiss, a new kind of biosensor can tell. A new and deceptively simple technique has been developed by chemists at Vanderbilt University that can measure the interactions between free-floating, unlabeled biological molecules including proteins, sugars, antibodies, DNA and RNA.

A researcher with the Monroe Carell Jr. Children's Hospital at Vanderbilt has been named the principal investigator for the largest-ever data review to examine the potential for serious cardiac side effects in children who take prescription medications for attention deficit hyperactivity disorder (ADHD).

Vanderbilt has received a $40 million Clinical and Translational Science Award (CTSA) - its largest ever government research grant - to expedite the translation of laboratory discoveries to patients in the community.

Men with prostate cancer now may have access to a new, minimally invasive surgical procedure. Urologic surgeons at Vanderbilt-Ingram Cancer Center will be the first in Tennessee to test the new Ablatherm procedure, which uses high-intensity focused ultrasound (HIFU) to destroy cancerous prostate tissue without any incision.

The Monroe Carell Jr. Children's Hospital at Vanderbilt has been named as one of the premiere children's hospitals in the nation by U.S. News & World Report.